Optimising therapy for spastic syndrome by combining baclofen with botulinumtoxin;Optimierte therapie des spastischen syndroms durch kombination von intrathekalem baclofen mit botulinumtoxin

Nervenarzt

Volumn 71, Issue 12, 2000, Pages 1007-1011

  Vogt, T ^a   Urban, P P ^a  

^a JOHANNES GUTENBERG UNIVERSITY   (Germany)

Author keywords

Botulinumtoxin; Intrathecal baclofen; Spasticity

Indexed keywords

BACLOFEN; BOTULINUM TOXIN A;

ADULT; ARTICLE; CASE REPORT; CEREBRAL PALSY; DRUG EFFICACY; DRUG INDICATION; DRUG INDUCED DISEASE; DRUG SAFETY; FEMALE; HUMAN; MALE; SPASTICITY; SPINAL CORD INJURY;

ADULT; BACLOFEN; BOTULINUM TOXIN TYPE A; DRUG THERAPY, COMBINATION; FEMALE; HUMANS; INJECTIONS, INTRAMUSCULAR; INJECTIONS, SPINAL; MALE; MIDDLE AGED; MUSCLE RELAXANTS, CENTRAL; MUSCLE SPASTICITY;

EID: 0033670014     PISSN: 00282804     EISSN: None     Source Type: Journal    
DOI: 10.1007/s001150050700     Document Type: Article

References (27)

1. Botulinum toxin for spasms and spasticity in the lower extremities
2. A randomized, double blind, placebo controlled trial of botulinum toxin in the treatment of spastic food in hemiparetic patients
3. The motor syndrome associated with exaggerated inhibition within the primary motor cortex of patients with hemispheric stroke
4. Pathophysiological aspects of spasticity in man
5. Local botulinum toxin in the treatment of spastic food drop
6. Intrathecal baclofen infusion and subsequent orthopedic surgery in patients with spastic cerebral palsy
7. Intrathecal baclofen for management of spastic cerebral palsy: Multicenter trial
8. Traditional pharmacological treatment for spasticity. Part I and II
9. Botulinumtoxin therapy for lower limb extensor spasticity
10. Botulinumtoxin A bei spastisch bedingten fehlstellungen
11. Management of spasticity in cerebral palsy with botulinum-A toxin: Report of a preliminary, randomized, double-blind trial
12. Cerebrospinal fluid pharmacokinetics of lumbar intrathecal baclofen
13. Use of spasmography to assess the effect of botulinum toxin type A in patients with lower limb spasticity
14. Clinicophysiologic concepts of spasticity and motor dysfunction in adults with upper motoneuron lesions
15. Die Bedeutung cutaneomuskularer Reflexe fur die Pathophysiologie. Diagnose und medikamentose Beeinflussbarkeit spastischer Syndrome
16. Botulinumtoxin A treatment of cerebral palsy
17. Management of spasticity with botulinum toxin type A: Implementing the treatment algorithm
18. Intrathecal baclofen for long-term treatment of spasticity. A multi-centre Study
19. Intrathecal baclofen alleviats spinal cord spasticity
20. Report of a double blind randomized study of intrathecal baclofen versus placebo
21. Treatment of cerebral origin spasticity with continuous intrathecal baclofen delivered via an implantable pump: Long-term follow-up review of 18 patients
22. Long-term intrathecal baclofen treatment in supraspinal spasticity
23. Evaluating the role of botulinum toxin type A in adults with focal spasticity
24. Intrathecal baclofen for intractable cerebral spasticity: A prospective placebo-controlled, double-blind study